...
首页> 外文期刊>Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus >Ligation-assisted endoscopic enucleation for treatment of esophageal subepithelial lesions originating from the muscularis propria: a preliminary study
【24h】

Ligation-assisted endoscopic enucleation for treatment of esophageal subepithelial lesions originating from the muscularis propria: a preliminary study

机译:结扎辅助内镜摘除术治疗源自固有肌层的食管上皮下病变:初步研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

An innovative ligation-assisted endoscopic enucleation (EE-L) technique was developed for the diagnosis and treatment of esophageal subepithelial lesions (smaller than 12mm) originating from muscularis propria by combining endoscopic band ligation and endoscopic enucleation techniques. The aim of the study was to evaluate efficacy and safety of EE-L technique in the treatment of esophageal subepithelial lesions (smaller than 12mm) originating from muscularis propria. Forty-seven esophageal subepithelial lesions (smaller than 12mm) originating from the muscularis propria in 44 patients were treated with EE-L between September 2010 and September 2012. The lesion was first aspirated into the transparent cap attached to the tip of endoscope. The elastic band was then released around its base. The purpose of ligation was to force the lesion to assume a polypoid form with a pseudostalk. Endoscopic enucleation was then performed until the tumor was completely enucleated from muscularis propria using a hook knife and forceps. All tumors (median diameter: 8.2 +/- 2.3mm, range: 4-12mm) were enucleated completely. Histopathology identified 45 tumors (95.7%) as leiomyoma, 2 (4.3%) tumors as gastrointestinal stromal tumor with very low risk. The mean time of the EE-L procedure was 12.5 +/- 4.6 minutes (range: 6-23 minutes). Two patients experienced self-limiting, non-life-threatening hemorrhage after EE-L. No perforation and massive hemorrhage requiring further endoscopic or surgical intervention occurred. There were no recurrences during the 6-24 months follow-up period. EE-L offers the option of localized treatment of small esophageal muscularis propria tumors (smaller than 12mm) with relatively few complications and low mortality, and provides the advantage of allowing a histopathological diagnosis. All the resected lesions in this study had a benign pathology.
机译:通过结合内镜带结扎和内镜摘除技术,开发了一种创新的结扎辅助内镜摘除术(EE-L)技术,用于诊断和治疗源自固有肌层的食管上皮下病变(小于12mm)。这项研究的目的是评估EE-L技术治疗源自固有肌层的食管上皮下病变(小于12mm)的有效性和安全性。在2010年9月至2012年9月之间,用EE-L治疗了44例源自固有肌层的47例食管上皮下病变(小于12mm)。该病变首先被吸到附着在内窥镜尖端的透明帽中。然后松开弹性带,使其围绕其底部。结扎的目的是迫使病变采取带有假茎的息肉状。然后进行内窥镜摘除术,直到使用钩刀和镊子将固有肌层完全摘除肿瘤为止。全部肿瘤(中值直径:8.2 +/- 2.3mm,范围:4-12mm)被完全摘除。组织病理学鉴定为平滑肌瘤的肿瘤为45个(95.7%),胃肠道间质瘤为2个(4.3%),风险极低。 EE-L程序的平均时间为12.5 +/- 4.6分钟(范围:6-23分钟)。两名患者在EE-L后经历了自限性,无生命危险的出血。没有发生需要进一步内窥镜或手术干预的穿孔和大出血。在6-24个月的随访期内无复发。 EE-L提供了较小的并发症,死亡率低的局部食管固有肌小肿瘤(小于12mm)的局部治疗方案,并具有组织病理学诊断的优势。本研究中所有切除的病变均具有良性病理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号